MSB 11.1% $1.10 mesoblast limited

Treatment not a drug.Paradigm shift toward cultural change...

  1. 1,658 Posts.
    lightbulb Created with Sketch. 168
    Treatment not a drug.
    Paradigm shift toward cultural change within FDA that indicates recognition of the science supporting an entire new constellation of treatment products and revolutions in SOCs for multiple indications.
    Recent announcement confirms direction and momentum of that cultural change in medical science posture of FDA.
    It's the signal LTSHs understand.
    The immunomodulatory/inflammatory mechanisms have been traditionally centre stage but the blockbuster sleeper over next 15 years is the regenerative actions in evidence with the RPD designation for HLHS and the potential treatments that will come, and even moreso the RPD designation opening up the FDA recognition of such life saving MOAs.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.10
Change
0.110(11.1%)
Mkt cap ! $1.255B
Open High Low Value Volume
97.0¢ $1.11 95.5¢ $15.75M 15.06M

Buyers (Bids)

No. Vol. Price($)
5 79396 $1.10
 

Sellers (Offers)

Price($) Vol. No.
$1.11 60351 4
View Market Depth
Last trade - 16.10pm 01/05/2024 (20 minute delay) ?
Last
$1.10
  Change
0.110 ( 10.8 %)
Open High Low Volume
96.5¢ $1.11 95.5¢ 2700730
Last updated 15.59pm 01/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.